Vioxx (rofecoxib) for osteoarthritis and acute pain

June 1999

Merck is starting to promote Vioxx (rofecoxib) for osteoarthritis and acute pain.

It's a new COX-2 inhibitor...similar to Celebrex (celecoxib).

Vioxx and Celebrex are comparable to NSAIDs for reducing pain and inflammation...but the new drugs MIGHT cause fewer ulcers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote